GGT - Overview: Gamma-Glutamyltransferase (GGT), Serum
Diagnosing and monitoring hepatobiliary disease, it is currently the most sensitive enzymatic indicator of liver disease Ascertaining whether observed elevations of alkaline phosphatase are due to skeletal disease (normal...
EHRC - Overview: Ehrlichia chaffeensis (HME) Antibody, IgG, Serum
An adjunct in the diagnosis of ehrlichiosis Seroepidemiological surveys of the prevalence of the infection in certain populations
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
GENRA - Overview: Gentamicin, Random, Serum
Monitoring adequacy of serum concentration during gentamicin therapy in specimens for which no collection timing information is provided
PBCU - Overview: Lead/Creatinine Ratio, Urine
Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.
LIPA1 - Overview: Lipoprotein(a), Serum
Cardiovascular disease (CVD) risk refinement in patients with moderate or high risk based on conventional risk factors or patients with clinical suspicion of residual CV risk not identified by other lipid parameters
LECT2 - Overview: Leukocyte Cell-Derived Chemotaxin 2 (LECT2), Immunostains Without Interpretation
Identification and classification of amyloid subtypes in tissue
IRF8 - Overview: Interferon Regulatory Factor 8 (IRF8) Immunostain, Technical Component Only
Identification of monoblasts in acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia
NF4FS - Overview: Neurofascin-155 IgG4, Flow Cytometry, Serum
Evaluating patients with an underlying demyelinating neuropathy Diagnosis of a neurofascin-155 IgG4 mediated neuropathy
TOBRA - Overview: Tobramycin, Random, Serum
Monitoring adequacy of serum concentration during tobramycin therapy This unit code is used whenever a specimen is submitted or collected without collection timing information. The phlebotomist should use this unit code if she or he does...
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.